Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungbin Han

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Information extraction from Korean radiology reports mingled two languageMiyoung Kwak, Seungbin Han, Jinwook Choi
Advanced Materials (Deerfield Beach, Fla.)|August 29, 2022
Thermal Transport Properties of Phonons in Halide PerovskitesYoonseong Jung, Wonsik Lee, Seungbin Han, et al.
Science Advances|February 4, 2026
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptorsPatrick Eiring, Maximilian J Steinhardt, Nele Bauer, et al.
Molecular & Cellular Proteomics : MCP|June 26, 2026
Proteome profiling reveals NQO2 activity contributing to proteasome inhibitor resistance in multiple myeloma cell linesChien-Yun Lee, Seungbin Han, Larissa Haertle, et al.
Haematologica|April 4, 2024
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myelomaUmair Munawar, Johanna Theuersbacher, Maximilian J Steinhardt, et al.
Hemasphere|January 24, 2025
Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple MyelomaXiang Zhou, Annika Hofmann, Benedict Engel, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
Haematologica|January 8, 2026
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myelomaSeungbin Han, Umair Munawar, Marietta Truger, et al.
Hemasphere|July 12, 2024
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myelomaLarissa Haertle, Umair Munawar, Hipólito N C Hernández, et al.
British Journal of Haematology|May 8, 2024
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker studyXiang Zhou, Vivien Wagner, Lukas Scheller, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Information extraction from Korean radiology reports mingled two languageMiyoung Kwak, Seungbin Han, Jinwook Choi
Advanced Materials (Deerfield Beach, Fla.)|August 29, 2022
Thermal Transport Properties of Phonons in Halide PerovskitesYoonseong Jung, Wonsik Lee, Seungbin Han, et al.
Science Advances|February 4, 2026
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptorsPatrick Eiring, Maximilian J Steinhardt, Nele Bauer, et al.
Molecular & Cellular Proteomics : MCP|June 26, 2026
Proteome profiling reveals NQO2 activity contributing to proteasome inhibitor resistance in multiple myeloma cell linesChien-Yun Lee, Seungbin Han, Larissa Haertle, et al.
Haematologica|April 4, 2024
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myelomaUmair Munawar, Johanna Theuersbacher, Maximilian J Steinhardt, et al.
Hemasphere|January 24, 2025
Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple MyelomaXiang Zhou, Annika Hofmann, Benedict Engel, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
Haematologica|January 8, 2026
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myelomaSeungbin Han, Umair Munawar, Marietta Truger, et al.
Hemasphere|July 12, 2024
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myelomaLarissa Haertle, Umair Munawar, Hipólito N C Hernández, et al.
British Journal of Haematology|May 8, 2024
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker studyXiang Zhou, Vivien Wagner, Lukas Scheller, et al.
Pageof 2